Emerging targeted combinations in the management of breast cancer
Rebecca J Lee, Anne C Armstrong, Andrew M WardleyDepartment of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UKAbstract: The number of targeted treatments has risen exponentially over the last few years and is an important concept in the fight against cance...
Guardado en:
Autores principales: | Lee RJ, Armstrong AC, Wardley AM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81dbad7e4a484275b69c9caab2920b29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New approaches in the management of advanced breast cancer – role of combination treatment with liposomal doxorubicin
por: Iain RJ Macpherson, et al.
Publicado: (2009) -
Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger LE, et al.
Publicado: (2013) -
Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer
por: Merriam PA, et al.
Publicado: (2011) -
Emerging role of brain metastases in the prognosis of breast cancer patients
por: Hambrecht A, et al.
Publicado: (2011) -
Targeting γ-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)